Results 181 to 190 of about 220,392 (312)

Trends in Nonsurgical Management for Low-Risk, Hormone Receptor-Positive Ductal Carcinoma In Situ. [PDF]

JAMA Netw Open
Matsui Y, Freeman JQ, Poland S, Howard FM, Chen N, Olopade OI, Huo D.   +6 more
europepmc   +1 more source

FGF-2 is overexpressed in myoepithelial cells of carcinoma ex-pleomorphic adenoma in situ structures

, 2010
Elizabeth Ferreira Martinez
openalex   +2 more sources

Prediction of pathologic upstaging in ductal carcinoma in situ using MRI radiomics combined with clinicopathological features. [PDF]

Breast Cancer Res
Bi C, Li Q, Deng L, Ren Z, Sun D, Ran F, Hu Z, Wang R, Sun S, Yang S, Chen A, Zhao R, Gao D, Wang J, Yang J.   +14 more
europepmc   +1 more source

Focal Adhesion Kinase and Wnt Signaling Regulate Human Ductal Carcinoma In Situ Stem Cell Activity and Response to Radiotherapy [PDF]

, 2014
Kathryn Williams, Nigel Bundred, Göran Landberg, Robert B. Clarke, Gillian Farnie   +4 more
openalex   +1 more source

Breast Events After Treatment of Ductal Carcinoma In Situ in Women: A Population-Based Study. [PDF]

Cancer Med
Chen Q, Campbell I, Elwood M, Cavadino A, Aye PS, Tin Tin S.   +5 more
europepmc   +1 more source

No Ink on Ductal Carcinoma In Situ: A Single Centre Experience [PDF]

, 2018
Piero Fregatti, Marco Gipponi, Francesca Depaoli, Federica Murelli, M. Guenzi, Elisabetta Bonzano, Marcello Ceppi, Daniele Friedman   +7 more
openalex   +1 more source

Efficacy and Safety of Guselkumab in Participants With Active Psoriatic Arthritis After Inadequate Response to One Prior Tumor Necrosis Factor Inhibitor: Week‐24 Results of a Phase 3, Randomized, Placebo‐Controlled Study

Arthritis &Rheumatology, EarlyView.
Objective To evaluate the efficacy and safety of guselkumab, an interleukin‐23p19 subunit inhibitor, in participants with active psoriatic arthritis (PsA) and inadequate response (inadequate efficacy and/or intolerance) to one prior tumor necrosis factor (TNF) inhibitor.
Alexis Ogdie, Joseph F. Merola, Philip J. Mease, Christopher T. Ritchlin, Jose U. Scher, Kimberly Parnell Lafferty, Daphne Chan, Soumya D. Chakravarty, Wayne Langholff, Yanli Wang, Jie Shao, Yevgeniy Krol, Alice B. Gottlieb   +12 more
wiley   +1 more source

Treatment of Biopsy-Proven Laryngeal Squamous Cell Carcinoma In Situ. [PDF]

Laryngoscope Investig Otolaryngol
Kaki PC, Patel AM, Huang L, Turner G, Haleem A, Brant JA, Brody RM, Carey RM.   +7 more
europepmc   +1 more source

p53 Alteration and Chromosomal Instability in Prostatic High-Grade Intraepithelial Neoplasia and Concurrent Carcinoma: Analysis by Immunohistochemistry, Interphase In Situ Hybridization, and Sequencing of Laser-Captured Microdissected Specimens [PDF]

, 2001
Jaudah Al‐Maghrabi, Lada Vorobyova, William Chapman, Michael A.S. Jewett, Maria Zieleńska, Jeremy A. Squire   +5 more
openalex   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source